Insider · CIK 0001405104
Gregory Norden
director
Files at PRAX (Praxis Precision Medicines, Inc.), RPRX (Royalty Pharma plc). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 26, 2025 | PRAX Praxis Precision Medicines, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +10,520 | $0.00 | $0 | 10,520 | Jun 27, 2025 |
| May 13, 2025 | RPRX Royalty Pharma plc | AGrant or award Class A Ordinary Shares | +7,614 | $0.00 | $0 | 83,688 | May 14, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.